- Q4 2023 Theriva Biologics Inc Earnings Call TranscriptMar 25, 2024$0.49377 (-5.04%)Earnings
- Q3 2023 Theriva Biologics Inc Earnings Call TranscriptNov 13, 2023$0.4402 (-6.34%)Earnings
- Q2 2023 Theriva Biologics Inc Earnings Call TranscriptAug 08, 2023$0.6272 (-2.15%)Earnings
- Q1 2023 Theriva Biologics Inc Earnings Call TranscriptMay 11, 2023$0.6888 (-3.33%)Earnings
- Q4 2022 Theriva Biologics Inc Earnings Call TranscriptMar 30, 2023$0.6801 (+0.01%)Earnings
- Q3 2022 Theriva Biologics Inc Earnings Call TranscriptNov 11, 2022$0.61675 (-3.90%)Earnings
- Theriva Biologics Inc KOL Webinar TranscriptNov 07, 2022
- Q2 2022 Synthetic Biologics Inc Earnings Call TranscriptAug 11, 2022$1.42Earnings
- Q1 2022 Synthetic Biologics Inc Earnings Call TranscriptMay 16, 2022$2.3 (+0.61%)Earnings
- Q4 2021 Synthetic Biologics Inc Earnings Call TranscriptMar 16, 2022$2.52 (+5.04%)Earnings
- Synthetic Biologics Inc Operational Update Call TranscriptDec 14, 2021
- Q3 2021 Synthetic Biologics Inc Earnings Call TranscriptNov 03, 2021$4.33 (-3.05%)Earnings
- Q2 2021 Synthetic Biologics Inc Earnings Call TranscriptAug 05, 2021$5.08 (-0.35%)Earnings
- Q1 2021 Synthetic Biologics Inc Earnings Call TranscriptMay 05, 2021$5.06 (-2.09%)Earnings
- Full Year 2020 Synthetic Biologics Inc Earnings Call TranscriptMar 04, 2021$5.8 (-9.99%)Earnings
- Q3 2020 Synthetic Biologics Inc Earnings Call TranscriptNov 10, 2020$3.42 (+3.64%)Earnings
- Q2 2020 Synthetic Biologics Inc Earnings Call TranscriptAug 06, 2020$5.95 (-0.45%)Earnings
- Q1 2020 Synthetic Biologics Inc Earnings Call TranscriptMay 05, 2020$3.48 (+2.21%)Earnings
- Q4 2019 Synthetic Biologics Inc Earnings Call TranscriptFeb 20, 2020$5 (-3.74%)Earnings
- Q3 2019 Synthetic Biologics Inc Earnings Call TranscriptNov 04, 2019$4.5 (+6.28%)Earnings
- Q2 2019 Synthetic Biologics Inc Earnings Call TranscriptAug 08, 2019$4.7 (+0.09%)Earnings
- Q1 2019 Synthetic Biologics Inc Earnings Call TranscriptMay 08, 2019$6.02 (-2.89%)Earnings
- Q4 2018 Synthetic Biologics Inc Earnings Call TranscriptFeb 27, 2019$6.5 (-2.40%)Earnings
Full Year 2020 Synthetic Biologics Inc Earnings Call Transcript
Good afternoon, and welcome to Synthetic Biologics' 2020 Year-end Investor Conference Call. (Operator Instructions) Please note, this event is being recorded. At this time, I would like to turn the call over to Vincent Perrone, Director, Corporate Communication at Synthetic Biologics. Please go ahead.
Thanks, Gary, and good afternoon, everyone. Welcome to Synthetic Biologics' 2020 year-end investor conference call. Today, I'm joined remotely by Steven Shallcross, Chief Executive and Financial Officer; Dr. Michael Kaleko, Senior Vice President, Research and Development; and Dr. Vince Wacher, Head of Product and Corporate Development.
Synthetic Biologics issued a press release this afternoon, which provided operational highlights and reported our financial results for the year ending December 31, 2020. The release can be found on the Investor Relations section of our website.
During our call today, we'll provide an operational update on our GI and microbiome
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)